Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical phenotypes and treatment patterns in men with chronic pelvic pain: a tertiary referral cohort.

International urology and nephrology·2026
Same author

Response to the Letter to the Editor on "Childhood Stress Urinary Incontinence in High-Impact Gymnasts: Does it Affect Their Future Risk of Adult SUI?"

International urogynecology journal·2026
Same author

Senescence-Driven Inflammation and Immune Dynamics in the Progression of Radiation Cystitis.

Cells·2026
Same author

Editorial Comment on "In Vitro Fertilization Utilization Rates and Outcomes in States With and Without Insurance Coverage Mandates for Male Infertility Care".

Urology·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Urinary Biomarkers for Radiation Cystitis: Current Insights and Future Directions.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jun 3, 2025

Nerve-sparing Mid-urethral Obstruction NeMO in Female Small Rodents
07:42

Nerve-sparing Mid-urethral Obstruction NeMO in Female Small Rodents

Published on: April 25, 2017

9.6K

Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study.

Karis Buford1, Haley Eisner1, Annah Vollstedt2

  • 1Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.

International Neurourology Journal
|January 7, 2025
PubMed
Summary
This summary is machine-generated.

Neuromodulation effectively treats neurogenic lower urinary tract dysfunction (NLUTD). Over 70% of patients with NLUTD advanced to stage 2 therapy after a successful neuromodulation trial.

Keywords:
Neurogenic bladderNeurogenic lower urinary tract dysfunctionNeuromodulationSpina bifida

More Related Videos

Cystometric and External Urethral Sphincter Measurements in Awake Rats with Implanted Catheter and Electrodes Allowing for Repeated Measurements
10:07

Cystometric and External Urethral Sphincter Measurements in Awake Rats with Implanted Catheter and Electrodes Allowing for Repeated Measurements

Published on: January 30, 2018

15.9K
Surgical Implantation of Chronic Neural Electrodes for Recording Single Unit Activity and Electrocorticographic Signals
08:26

Surgical Implantation of Chronic Neural Electrodes for Recording Single Unit Activity and Electrocorticographic Signals

Published on: February 24, 2012

47.3K

Related Experiment Videos

Last Updated: Jun 3, 2025

Nerve-sparing Mid-urethral Obstruction NeMO in Female Small Rodents
07:42

Nerve-sparing Mid-urethral Obstruction NeMO in Female Small Rodents

Published on: April 25, 2017

9.6K
Cystometric and External Urethral Sphincter Measurements in Awake Rats with Implanted Catheter and Electrodes Allowing for Repeated Measurements
10:07

Cystometric and External Urethral Sphincter Measurements in Awake Rats with Implanted Catheter and Electrodes Allowing for Repeated Measurements

Published on: January 30, 2018

15.9K
Surgical Implantation of Chronic Neural Electrodes for Recording Single Unit Activity and Electrocorticographic Signals
08:26

Surgical Implantation of Chronic Neural Electrodes for Recording Single Unit Activity and Electrocorticographic Signals

Published on: February 24, 2012

47.3K

Area of Science:

  • Urology
  • Neurology
  • Medical Devices

Background:

  • Neurogenic lower urinary tract dysfunction (NLUTD) significantly impacts patients with neurologic disorders.
  • Implantable neuromodulation has shown promise in managing NLUTD symptoms.

Purpose of the Study:

  • To evaluate the experience with sacral and pudendal neuromodulation in patients diagnosed with NLUTD.
  • To assess the feasibility and effectiveness of neuromodulation for NLUTD.

Main Methods:

  • Retrospective chart review of patients with neurogenic bladder (ICD-9/10 codes) from 2008-2020.
  • Analysis of demographic and clinical data, including neurologic diagnosis, voiding symptoms, fecal incontinence, and intermittent catheterization.
  • Assessment of patient progression to stage 2 implantable pulse generator (IPG) placement based on symptom improvement (>50%).

Main Results:

  • Eighty-two patients with neurologic diagnoses underwent stage 1 neuromodulation.
  • Common diagnoses included diabetic cystopathy, spinal surgery complications, and spinal cord injury.
  • Urinary urgency and urge urinary incontinence were the most frequent symptoms. Overall, 71.95% advanced to stage 2 IPG placement.

Conclusions:

  • Neuromodulation is a feasible and effective treatment option for NLUTD.
  • Further research is recommended to explore the broader utilization of neuromodulation in NLUTD management.